AZN

#4495
AstraZeneca PLC
208.40
+1.89%
セクター:
ベース:
利益通貨:
日中レンジ
208.40
208.40
1年のレンジ
61.24
212.71
1日の変化
+1.89%
月次変化
+123.68%
6か月変化
+160.63%
1年の変化
+174.97%
以前の終値
204.53
Open
208.40
Bid
Ask
Low
208.40
High
208.40
ボリューム
1
Open full chart

Financials

Overview 明細書 Statistics Dividends
Quarterly Annual
  • Market Capitalization N/A
  • Employee 94 K
  • Founded 1999
  • CEO Pascal Soriot
  • Website www.astrazeneca.com
  • Headquarter United Kingdom
  • FIGI BBG000BZ0DK8
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
—
Price to sales ratio
—
Dividends per share
—
Dividend yield %
—

AstraZeneca PLC - American Depositary Shares

AstraZeneca plc is a Swedish-British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, UK. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Zeneca shareholders received 53.5% of the shares, while Astra shareholders received the remaining 46.5%. Its portfolio includes primary and speciality care, coverage for rare diseases, and a robust global presence across various regions. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, UK; Gothenburg, Sweden; and Gaithersburg, Maryland, US. AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje.

ニュース